MedPath

Senna Laxative

Drug Facts

Approved
Approval ID

2b03d07c-ea4f-4663-bcc3-20ebdf83b7aa

Product Type

HUMAN OTC DRUG LABEL

Effective Date

May 21, 2025

Manufacturers
FDA

PD-Rx Pharmaceuticals, Inc.

DUNS: 156893695

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Senna

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43063-838
Application NumberM007
Product Classification
M
Marketing Category
C200263
G
Generic Name
Senna
Product Specifications
Route of AdministrationORAL
Effective DateMay 21, 2025
FDA Product Classification

INGREDIENTS (7)

CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSInactive
Code: L11K75P92J
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
MINERAL OILInactive
Code: T5L8T28FGP
Classification: IACT
SENNOSIDES A AND BActive
Quantity: 8.6 mg in 1 1
Code: 1B5FPI42EN
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 5/15/2012

43063838 Label

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 5/15/2012

Uses

  • relieves occasional constipation (irregularity)

  • this product generally produces a bowel movement in 6 to 12 hours

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 5/15/2012

Active ingredient (in each tablet)

Sennosides 8.6mg

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 5/15/2012

Purpose

Laxative

WARNINGS SECTION

LOINC: 34071-1Updated: 5/15/2012

Warnings

Do not use

for more than one week unless directed by a doctor

Ask a doctor before use if you

  • have abdominal pain, nausea, or vomiting
  • are taking mineral oil
  • noticed a sudden change in bowel habits that last over 2 weeks

Stop use and ask a doctor if

  • you have no bowel movement within 12 hours
  • you have rectal bleeding

These could be signs of a serious condition

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 5/15/2012

Directions

  • do not exceed recommended dose

Age

Starting Dose

Maximum Dose

adults and children 12 years of age and older

2 tablets once a day preferably at bedtime; increase if needed, or as directed by a doctor

4 tablets twice a day, in the morning and at bedtime

children under 12 years

ask a doctor

ask a doctor

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 5/15/2012

Other information

***Tamper Evident:**Do not use if safety seal is broken or missing from bottle.

  • each tablet contains: calcium 20 mg, potassium 70 mg

  • store at room temperature

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 5/15/2012

Inactive ingredients:

croscarmellose sodium, dicalcium phosphate, hypromellose, magnesium stearate, microcrystalline cellulose, mineral oil

OTC - QUESTIONS SECTION

LOINC: 53413-1Updated: 5/15/2012

Questions?

Adverse drug event call: (866) 562-2756

HOW SUPPLIED SECTION

LOINC: 34069-5Updated: 11/20/2018

16 HOW SUPPLIED

Senna Laxative Tablets are available as follows:

8.6 mg: Brown, round, scored tablet, debossed “SB”. Available in bottles of

10 tablets (NDC 43063-838-10)

30 tablets (NDC 43063-838-30)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Senna Laxative - FDA Drug Approval Details